Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide. Discovered 30
years ago, it is produced as a consequence of alternative RNA processing of the calcitonin …

Calcitonin gene-related peptide (CGRP) is a highly potent vasoactive peptide released from
sensory nerves, which is now proposed to have protective effects in several cardiovascular …

Nitroxyl (HNO) is a redox sibling of nitric oxide (NO) that targets distinct signalling pathways
with pharmacological endpoints of high significance in the treatment of heart failure …

Migraine is a common episodic neurovascular brain disorder associated with increased risk
of cardio-and cerebrovascular ischemia. Migraine headache is likely caused by activation of …

Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the
pathophysiology of migraine. Blockade of CGRP is a new therapeutic target for patients with …

α-Calcitonin gene-related peptide (α-CGRP) is a regulatory neuropeptide of 37 amino acids.
It is widely distributed in the central and peripheral nervous system, predominantly in cell …

Pulmonary hypertension (PH) is an incurable, chronic disease of small pulmonary vessels.
Progressive remodeling of the pulmonary vasculature results in increased pulmonary …

The advent of medical nutrition therapy and nutritional physiology affords the opportunity to
link diet to specific cardiovascular mechanisms, suggesting novel treatments for …

CGRP and specific CGRP receptors are found in the heart where they produce positive-
inotropic and anti-apoptotic effects, key adaptations to exercise and cardiovascular disease …

Increasing knowledge about the role of calcitonin gene-related peptide (CGRP) in migraine
pathophysiology has led to the development of antibodies against this peptide or its …